Roger Deaton

1.2k total citations
11 papers, 914 citations indexed

About

Roger Deaton is a scholar working on Psychiatry and Mental health, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Roger Deaton has authored 11 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 5 papers in Surgery and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Roger Deaton's work include Epilepsy research and treatment (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Cardiovascular Syncope and Autonomic Disorders (3 papers). Roger Deaton is often cited by papers focused on Epilepsy research and treatment (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Cardiovascular Syncope and Autonomic Disorders (3 papers). Roger Deaton collaborates with scholars based in United States, United Kingdom and Canada. Roger Deaton's co-authors include Kenneth W. Sommerville, Stephen D. Silberstein, Joel R. Saper, Sou-Yie Chu, Christopher Silber, Alan M. Rapoport, Laura I. Rankin, N. T. Mathew, Seymour Solomon and Herbert G. Markley and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and European Heart Journal.

In The Last Decade

Roger Deaton

11 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Deaton United States 11 600 258 252 237 142 11 914
Darcy Vavrek United States 16 264 0.4× 232 0.9× 144 0.6× 146 0.6× 260 1.8× 27 916
Candace Bramson United States 15 110 0.2× 329 1.3× 51 0.2× 150 0.6× 317 2.2× 36 823
Jane Saiers United States 15 771 1.3× 412 1.6× 79 0.3× 511 2.2× 23 0.2× 21 1.0k
Craig Kornick United States 11 57 0.1× 137 0.5× 186 0.7× 122 0.5× 119 0.8× 12 844
Paula Burger United States 6 127 0.2× 171 0.7× 141 0.6× 15 0.1× 93 0.7× 9 564
E. H. Reynolds United Kingdom 13 400 0.7× 92 0.4× 361 1.4× 17 0.1× 44 0.3× 24 884
Ronald C. Reed United States 17 569 0.9× 49 0.2× 462 1.8× 57 0.2× 35 0.2× 42 789
Daniel T. Barratt Australia 16 79 0.1× 165 0.6× 296 1.2× 22 0.1× 149 1.0× 34 952
David Weintraub United States 10 519 0.9× 44 0.2× 514 2.0× 42 0.2× 197 1.4× 13 829
Clara C. Faura Spain 15 59 0.1× 363 1.4× 306 1.2× 19 0.1× 185 1.3× 20 1.0k

Countries citing papers authored by Roger Deaton

Since Specialization
Citations

This map shows the geographic impact of Roger Deaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Deaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Deaton more than expected).

Fields of papers citing papers by Roger Deaton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Deaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Deaton. The network helps show where Roger Deaton may publish in the future.

Co-authorship network of co-authors of Roger Deaton

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Deaton. A scholar is included among the top collaborators of Roger Deaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Deaton. Roger Deaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Vo, Pamela, Roger Deaton, Xionghua Wu, et al.. (2014). Respiratory syncytial virus-related hospitalization in premature infants without bronchopulmonary dysplasia: subgroup efficacy analysis of the IMpact-RSV trial by gestational age group. SHILAP Revista de lepidopterología. 43–43. 15 indexed citations
2.
Torp‐Pedersen, Christian, Ian D. Caterson, Walmir Coutinho, et al.. (2007). Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. European Heart Journal. 28(23). 2915–2923. 96 indexed citations
3.
Pellock, John M., et al.. (2002). Acute Pancreatitis Coincident with Valproate Use: A Critical Review. Epilepsia. 43(11). 1421–1424. 42 indexed citations
4.
Sackellares, J. Chris, Gregory L. Krauss, Kenneth W. Sommerville, & Roger Deaton. (2002). Occurrence of Psychosis in Patients with Epilepsy Randomized to Tiagabine or Placebo Treatment. Epilepsia. 43(4). 394–398. 21 indexed citations
5.
Freitag, Frederick G., H. A. Carlson, Jerome Goldstein, et al.. (2002). A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 58(11). 1652–1659. 213 indexed citations
6.
Dodrill, Carl B., et al.. (2000). Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood. Epilepsy Research. 42(2-3). 123–132. 24 indexed citations
7.
Hogan, R. Edward, Mary Bertrand, Roger Deaton, & Kenneth W. Sommerville. (2000). Total percentage body weight changes during add-on therapy with tiagabine, carbamazepine and phenytoin. Epilepsy Research. 41(1). 23–28. 38 indexed citations
8.
Leppik, Ilo E., Lennart Gram, Roger Deaton, & Kenneth W. Sommerville. (1999). Safety of tiagabine: summary of 53 trials. Epilepsy Research. 33(2-3). 235–246. 62 indexed citations
9.
Mathew, N. T., Joel R. Saper, Stephen D. Silberstein, et al.. (1995). Migraine Prophylaxis With Divalproex. Archives of Neurology. 52(3). 281–286. 261 indexed citations
10.
Chu, Sou-Yie, et al.. (1993). Single‐ and Multiple‐dose Pharmacokinetics of Clarithromycin, a New Macrolide Antimicrobial. The Journal of Clinical Pharmacology. 33(8). 719–726. 61 indexed citations
11.
Chu, Sou-Yie, Roger Deaton, & John C. Cavanaugh. (1992). Absolute bioavailability of clarithromycin after oral administration in humans. Antimicrobial Agents and Chemotherapy. 36(5). 1147–1150. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026